Healthcare -
Biotechnology - NASDAQ - US
$ 9.94
7.81 %
$ 220 M
Market Cap
-4.56
P/E
INMB - CASH & EQUIVALENTS
Cash & Equivalents INMB - INmune Bio, Inc.
35.8 M
LAST VALUE
-30.78%
2 YEAR CAGR
186.35%
5 YEAR CAGR
0.00%
10 YEAR CAGR